| Investigations into viomycin biosynthesis by using heterologous production in Streptomyces lividans. | |
| | |
MedLine Citation:
|
PMID: 19105177 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Viomycin and capreomycin are members of the tuberactinomycin family of antituberculosis drugs. As with many antibacterial drugs, resistance to the tuberactinomycins is problematic in treating tuberculosis; this makes the development of new derivatives of these antibiotics to combat this resistance of utmost importance. To take steps towards developing new derivatives of this family of antibiotics, we have focused our efforts on understanding how these antibiotics are biosynthesized by the producing bacteria so that metabolic engineering of these pathways can be used to generate desired derivatives. Here we present the heterologous production of viomycin in Streptomyces lividans 1326 and the use of targeted-gene deletion as a mechanism for investigating viomycin biosynthesis as well as the generation of viomycin derivatives. Deletion of vioQ resulted in nonhydroxylated derivatives of viomycin, while strains lacking vioP failed to acylate the cyclic pentapeptide core of viomycin with beta-lysine. Surprisingly, strains lacking vioL produced derivatives that had the carbamoyl group of viomycin replaced by an acetyl group. Additionally, the acetylated viomycin derivatives were produced at very low levels. These two observations suggested that the carbamoyl group of the cyclic pentapeptide core of viomycin was introduced at an earlier step in the biosynthetic pathway than previously proposed. We present biochemical evidence that the carbamoyl group is added to the beta-amino group of L-2,3-diaminopropionate prior to incorporation of this amino acid by the nonribosomal peptide synthetases that form the cyclic pentapeptide cores of both viomycin and capreomycin. |
| | |
Authors:
|
John J Barkei; Brian M Kevany; Elizabeth A Felnagle; Michael G Thomas |
Related Documents
:
|
4010487 - Preparation of hydroperoxy and hydroxy derivatives of rat liver phosphatidylcholine and... 10320347 - 13c nmr study of how the oxyanion pka values of subtilisin and chymotrypsin tetrahedral... 16095297 - A convenient entry to c2- and c3-substituted gulono-gamma-lactone derivatives from l-as... 19679107 - Metabolism and biological production of resolvins derived from docosapentaenoic acid (d... 17479227 - Fermentation of pretreated sugarcane bagasse hemicellulose hydrolysate to ethanol by pa... 21080667 - Binding of carboxylic acids by fluorescent pyridyl ureas. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Chembiochem : a European journal of chemical biology Volume: 10 ISSN: 1439-7633 ISO Abbreviation: Chembiochem Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2009-01-21 Completed Date: 2009-03-05 Revised Date: 2010-12-03 |
Medline Journal Info:
|
Nlm Unique ID: 100937360 Medline TA: Chembiochem Country: Germany |
Other Details:
|
Languages: eng Pagination: 366-76 Citation Subset: IM |
Affiliation:
|
Department of Bacteriology, University of Wisconsin-Madison, 6155 Microbial Sciences Building, 1550 Linden Drive, Madison, WI 53706, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acids
/
metabolism Antitubercular Agents / metabolism* Bacterial Proteins / genetics, metabolism Gene Deletion Multigene Family Streptomyces lividans / genetics, metabolism* Viomycin / biosynthesis* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 AI065850/AI/NIAID NIH HHS; R01 AI065850-03/AI/NIAID NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Amino Acids; 0/Antitubercular Agents; 0/Bacterial Proteins; 32988-50-4/Viomycin |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo.
Next Document: Investigating sample pooling strategies for DIGE experiments to address biological variability.